Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
QMS Medical Allied ServicesNSE:QMSMEDI -1.11%77 Altman Z-Score is 2.63 as of Jul. 22, 2026, which is 22% below its 10-year median of 3.38. GuruFocus rates NSE:QMSMEDI with a GF Score™ of 77/100 and a GF Value™ of ₹120.61 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 807 Medical Devices & Instruments companies, QMS Medical Allied Services ranks worse than 53.9% on this metric.
The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.
Warning Sign:
Altman Z-score of 2.66 is in the grey area. This implies that the company is under some kind of financial stress. If it is below 1.8, the company may face bankruptcy risk.
QMS Medical Allied Services has a Altman Z-Score of 2.63, indicating it is in Grey Zones. This implies that QMS Medical Allied Services is in some kind of financial stress. If it is below 1.81, the company may face bankrupcy risk.
The zones of discrimination were as such:
When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.
The historical rank and industry rank for QMS Medical Allied Services's Altman Z-Score or its related term are showing as below:
NSE:QMSMEDI'
s Altman Z-Score Range Over the Past 10 Years
Min: 2.45 Med: 3.38 Max: 4.83
Current: 2.66
During the past 7 years, QMS Medical Allied Services's highest Altman Z-Score was 4.83. The lowest was 2.45. And the median was 3.38.
QMS Medical Allied Services (NSE:QMSMEDI) Altman Z-Score Explanation
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.
X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QMSMEDI vs ISRG, BDX, MDLN: Altman Z-Score Comparison
For the Medical Instruments & Supplies subindustry, QMS Medical Allied Services's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
QMS Medical Allied Services Altman Z-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, QMS Medical Allied Services's Altman Z-Score distribution charts can be found below:
* The bar in red indicates where QMS Medical Allied Services's Altman Z-Score falls into.
QMS Medical Allied Services Altman Z-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.
QMS Medical Allied Services (NSE:QMSMEDI) has a Altman Z-Score of 2.63 as of Jul. 22, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on QMS Medical Allied Services and its competitors. This is 22% below median its historical median of 3.38. Over the past decade, QMS Medical Allied Services' Altman Z-Score has ranged from 2.45 to 4.83. According to the industry distribution chart, QMS Medical Allied Services ranks #435 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 53.9%.
Is QMS Medical Allied Services' Altman Z-Score too high?
QMS Medical Allied Services' current Altman Z-Score of 2.63 is 22% below median its 10-year median of 3.38. Over the past 10 years, this metric has ranged from a low of 2.45 to a high of 4.83. The Medical Devices & Instruments industry median Altman Z-Score is 2.95. QMS Medical Allied Services' value of 2.63 is 10.8% below this industry median. Based on the distribution chart, QMS Medical Allied Services ranks #435 out of 807 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, QMS Medical Allied Services has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does QMS Medical Allied Services' Altman Z-Score compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, QMS Medical Allied Services ranks #435 out of 807 companies for Altman Z-Score. This places QMS Medical Allied Services in the lower half of its industry. The industry median Altman Z-Score is 2.95. QMS Medical Allied Services' value of 2.63 is 10.8% below this benchmark. Historically, QMS Medical Allied Services' own Altman Z-Score has ranged from 2.45 to 4.83 over the past decade. While the company's 10-year median is 3.38 vs. the industry median of 2.95, QMS Medical Allied Services has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Medical Devices & Instruments company?
The median Altman Z-Score among Medical Devices & Instruments companies is 2.95, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. QMS Medical Allied Services's current Altman Z-Score of 2.63 is 10.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on QMS Medical Allied Services and its competitors. For the Medical Devices & Instruments industry, the median Altman Z-Score is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. QMS Medical Allied Services's current Altman Z-Score is 2.63, which is 22% below median its own 10-year median of 3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QMS Medical Allied Services stock overvalued right now?
Based on GuruFocus' analysis, QMS Medical Allied Services (NSE:QMSMEDI) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹120.61, compared to a current price of ₹106.96 — trading 11.3% below its estimated fair value. The current Altman Z-Score is 2.63, which is 22% below median its 10-year median of 3.38 and 10.8% below the Medical Devices & Instruments industry median of 2.95. QMS Medical Allied Services' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For QMS Medical Allied Services (NSE:QMSMEDI), the current Altman Z-Score is 2.63 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is QMS Medical Allied Services (NSE:QMSMEDI) Overvalued in 2026?
Based on GuruFocus' analysis, QMS Medical Allied Services stock appears to be undervalued.
The current stock price of ₹106.96 is trading 11.3% below its estimated GF Value™ of ₹120.61.
GuruFocus considers QMS Medical Allied Services to be Modestly Undervalued.
Key valuation signals for NSE:QMSMEDI:
Altman Z-Score: 2.63 (22% below median its 10-year median of 3.38)
GF Value™: ₹120.61 vs. price of ₹106.96 (11.3% below fair value)
Industry Position: 10.8% below the Medical Devices & Instruments median (#435 of 807)
No single metric tells the full story. See the NSE:QMSMEDI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
QMS Medical Allied Services Ltd is engaged in the marketing and distribution of a wide range of medical products as well as medical education services. The company's products are sold under brand name "QDevices" and also manage the distribution for other brands such as 3M, Heine, Rossmax and others. It offers medical products such as Blood Pressure Monitors, Glucose Monitoring Kits and strips, Dental Products, Personal protection kits eg-PPE kits, Infection prevention, Stethoscope and Oxygen Concentrator.
77GF Score
Get the complete analysis for NSE:QMSMEDI
Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QMSMEDI has been successfully added to your 
